Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Why ERS Early Career Members should attend the International Congress 2019 in Madrid

Niki Ubags, Manuela Platé, Isaac Almendros, Sabine Bartel
Breathe 2019 15: 128-130; DOI: 10.1183/20734735.0018-2019
Niki Ubags
1Faculty of Biology and Medicine, University of Lausanne, Service de Pneumologie, CHUV, Epalinges, Switzerland
6These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Platé
2Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, UK
6These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isaac Almendros
3Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
4Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Isaac Almendros
Sabine Bartel
5University of Groningen, University Medical Center Groningen, Dept of Pathology and Medical Biology, GRIAC Research Institute, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sabine Bartel
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The #ERSCongress is the largest respiratory conference worldwide. This article points out why
@ERSTalk Early Career Members can especially benefit from attending this huge event and gives upcoming fellowship deadlines.
http://ow.ly/3GQ530o8Ezh

The European Respiratory Society (ERS) International Congress will take place from September 28 to October 2, 2019, in Madrid, Spain, and as every year, the rich and diverse programme will be full of opportunities for ERS Early Career Members (ECMs). Alongside all the outstanding scientific sessions, which are aimed at physicians, physician-­researchers and basic researchers in all fields related to pulmonary medicine, the Early Career Member Committee (ECMC) also organises several sessions dedicated to the professional development of ECMs.

Accordingly, every year the ECMC organises an ECM Session (Tuesday, October 1, from 14:45 to 16:45). This session is specially developed to fit the needs of ECMs, and to provide useful information on topics related to career development, fellowships, and tips and tricks on how to become more involved in the ERS [1]. This year's session will be focused on “Effective communication of your science”. Effective communication is part of the everyday life for each physician, scientist or allied respiratory professional, be it communicating scientific advancements in diagnostics or therapies to patients, giving presentations at conferences or even writing papers and proposals. In addition, proper and correct communication of scientific facts to the general public becomes increasingly important in a world of social media and so-called fake news. Furthermore, defining measures for effective public outreach is a prerequisite for virtually all successful future grant applications; thus, scientists and clinicians should be trained early on in this aspect. The ECM session will provide two presentations on:

  • making yourself and your science memorable at the congress

  • strategies to effectively communicate science to patients and the wider public

The presentations will be followed by a panel discussion with the speakers. During the ECM session, the ECMC chair Lieuwe Bos will give an overview of what the ECMC can do for you and how you can get involved in tasks that are available to the ECMs. These presentations will be followed by a networking event that provides you with the ideal opportunity to meet and interact with fellow ECMs while enjoying a drink and some tapas.

Excellent learning and development opportunities for ECMs are also offered by Professional Development Workshops. These aim to provide participants with practical tips and guidelines on how to use new skills and knowledge, and apply them in a practical setting. The list of workshops can be found in the programme on the Congress website (https://erscongress.org/) and you usually need to register online in advance. In particular, we would like to draw attention to the workshop “Ethical issues in clinical respiratory research – where to draw the line?” that is organised by the ECMC. Expert speakers will lead a discussion on not only scientific advances but also ethical considerations that need to be taken into account by focusing on two novel technologies: clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system-based genome editing and the use of (modified) stem cell therapies. CRISPR/Cas9 is a bacterial protein–RNA complex. It consists of an exonuclease introducing double-strand DNA breaks, which is the Cas9 protein, and a guide RNA that specifically directs the latter to the location of interest in the genome [2]. Thus, after the induction of a double-strand break an additionally supplied (modified) gene construct can be incorporated into the DNA by homologous recombination. Thereby, the CRISPR/Cas9 system represents an easy-to-use molecular tool that is able to delete entire genes, to insert super-exon donors to activate gene expression or even to edit single base pairs to correct mutations, and can basically be handled by every skilled researcher in every laboratory [3]. Accordingly, it is currently being heavily investigated for its potential in the treatment of monogenetic lung diseases, such as α1-antitrypsin deficiency or cystic fibrosis [4, 5]. Albeit that the CRISPR/Cas9 genome modification technology seems very promising, it has to be noted that its safety and potential off-target effects, especially for treating human disease, have not yet been clarified.

Thus, in the first part of this course, an experienced pulmonary researcher will describe the tremendous potential associated with the CRISPR/Cas9 technology [5] but will also inform the audience about current knowledge gaps and putative problems. This will be followed by a talk by an expert on bioethics, focusing on the bioethical considerations that should be taken into account when working with this new technology [6].

In the second part of the workshop, an expert in stem cell therapies, and the production and application of human stem cells [7] will describe the potential of those cells for therapy and discuss current gaps in knowledge and pitfalls. Again, this will be followed by a talk pointing out ethical pitfalls and points of care when developing stem-cell based therapies [8]. Both parts will be followed by interactive group discussions, with pro/con debates and discussions of examples brought up by participants. Considering the recent heated debate sparked by the work of He Jiankui of the Southern University of Science and Technology in Shenzhen, China, who claimed to have altered the genomes of twin baby girls born in November to make the children's cells resistant to infection by HIV, this workshop is particularly topical, and covers important scientific and ethical questions in an interactive way that will favour audience participation and discussion of different points of view.

In summary, the ERS Congress offers various possibilities for ECMs to proceed in their professional development, besides presenting their data and meeting with experts in the field. The ECMC is looking forward to meeting you in Madrid!

ERS fellowship opportunities for ECMs: upcoming deadlines

Alongside organising career developmental sessions at the Congress, the ERS also provides a wide variety of fellowships to foster individual professional advancement of ECMs. These fellowships provide a unique opportunity to young researchers and clinicians to expand their knowledge in another institution within Europe. Thereby, the ERS offers different types of grants depending on the duration of the fellowship. Specifically, the next deadlines for the Short-Term Research Fellowships (1–3 months' duration) will be on October 1, 2019, and on April 1, 2020. For longer periods, ERS offers the Long-Term Research Fellowships (from 6 months to up 1 year). The call deadline will be during January 2020.

The Clinical Training Fellowships provide the opportunity for qualified clinicians to expand their expertise in other techniques in a host institution for up to 6 months. There are two calls per year, next deadlines being October 1, 2019, and April 1, 2020.

ERS also hopes to launch further fellowships later in 2019, which will all be published at https://www.ersnet.org/professional-development/fellowships.

Footnotes

  • Conflict of interest: N. Ubags has nothing to disclose.

  • Conflict of interest: M. Platé has nothing to disclose.

  • Conflict of interest: I. Almendros has nothing to disclose.

  • Conflict of interest: S. Bartel reports a grant and personal fees for advisory board membership from Bencard Allergie GmbH outside the submitted work.

  • Support statement S. Bartel is supported by an ERS/European Union (EU) RESPIRE 3 Marie Sklodowska-Curie Fellowship and the ERS and the EU Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement number 713406.

  • Copyright ©ERS 2019
http://creativecommons.org/licenses/by-nc/4.0/

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Nenna R,
    2. Petrarca L,
    3. Parisi GF, et al.
    Zooming in on the ERS fellowships and the International Congress. Breathe 2018; 14: 141–144.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Hsu PD,
    2. Lander ES,
    3. Zhang F
    . Development and applications of CRISPR–Cas9 for genome engineering. Cell 2014; 157: 1262–1278.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Oude Blenke E,
    2. Evers MJW,
    3. Mastrobattista E, et al.
    CRISPR–Cas9 gene editing: delivery aspects and therapeutic potential. J Control Release 2016; 244: 139–148.
    OpenUrl
  4. ↵
    1. Shen S,
    2. Sanchez ME,
    3. Blomenkamp K, et al.
    Amelioration of alpha-1 antitrypsin deficiency diseases with genome editing in transgenic mice. Hum Gene Ther 2018; 29: 861–873.
    OpenUrl
  5. ↵
    1. Hart SL,
    2. Harrison PT
    . Genetic therapies for cystic fibrosis lung disease. Curr Opin Pharmacol 2017; 34: 119–124.
    OpenUrl
  6. ↵
    1. Neuhaus CP,
    2. Caplan AL
    . Genome editing: bioethics shows the way. PLoS Biol 2017; 15: e2001934.
    OpenUrl
  7. ↵
    1. Agha E E,
    2. Kramann R,
    3. Schneider RK, et al.
    Mesenchymal stem cells in fibrotic disease. Cell Stem Cell 2017; 21: 166–177.
    OpenUrl
  8. ↵
    1. Lysaght T,
    2. Kerridge IH,
    3. Sipp D, et al.
    Ethical and regulatory challenges with autologous adult stem cells: a comparative review of international regulations. J Bioeth Inq 2017; 14: 261–273.
    OpenUrl
PreviousNext
Back to top
Vol 15 Issue 2 Table of Contents
Breathe: 15 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Why ERS Early Career Members should attend the International Congress 2019 in Madrid
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Why ERS Early Career Members should attend the International Congress 2019 in Madrid
Niki Ubags, Manuela Platé, Isaac Almendros, Sabine Bartel
Breathe Jun 2019, 15 (2) 128-130; DOI: 10.1183/20734735.0018-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Why ERS Early Career Members should attend the International Congress 2019 in Madrid
Niki Ubags, Manuela Platé, Isaac Almendros, Sabine Bartel
Breathe Jun 2019, 15 (2) 128-130; DOI: 10.1183/20734735.0018-2019
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • ERS fellowship opportunities for ECMs: upcoming deadlines
    • Footnotes
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Early career forum

  • Interview with the ECM Awardee 2022 and introducing the new ECM members
  • Preview of the 2023 LSC and Sleep and Breathing conferences
  • Highlights of the ERS Lung Science Conference 2022
Show more Early career forum

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society